Early Survival and Safety of ALPPS First Report of the International ALPPS Registry

Carregando...
Imagem de Miniatura
Citações na Scopus
382
Tipo de produção
article
Data de publicação
2014
Editora
LIPPINCOTT WILLIAMS & WILKINS
Indexadores
Título da Revista
ISSN da Revista
Título do Volume
Autores
SCHADDE, Erik
ARDILES, Victoria
ROBLES-CAMPOS, Ricardo
MALAGO, Massimo
HERNANDEZ-ALEJANDRO, Roberto
SOUBRANE, Olivier
SCHNITZBAUER, Andreas A.
RAPTIS, Dimitri
TSCHUOR, Christoph
Autor de Grupo de pesquisa
ALPPS Registry Grp
Editores
Coordenadores
Organizadores
Citação
ANNALS OF SURGERY, v.260, n.5, p.829-838, 2014
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Objectives: To assess safety and outcomes of the novel 2-stage hepatectomy, Associating Liver Partition and Portal Vein Ligation for Staged Hepatectomy (ALPPS), using an international registry. Background: ALPPS induces accelerated growth of small future liver remnants (FLR) to allow curative resection of liver tumors. There is concern about safety based on reports of higher morbidity and mortality. Methods: A Web-based data entry system was created with password access and data pseudoencryption (NCT01924741). All patients with complete 90-day data were included. Multivariate logistic regression analysis was performed to identify independent risk factors for severe complications and mortality and volume growth of the FLR. Results: Complete data were available for 202 patients. A total of 141 (70%) patients had colorectal liver metastases (CRLM). Median starting standardized future liver remnants of 21% increased by 80% within a median of 7 days. Ninety-day mortality was 19/202 (9%). Severe complications including mortalities (Clavien-Dindo >= IIIb) occurred in 27% of patients. Independent factors for severe complications were red blood cell transfusion [odds ratio (OR), 5.2), ALPPS stage I operating time greater than 300 minutes (OR, 4.4), age more than 60 years (OR, 3.8), and non-CRLM (OR, 2.7). Age, use of Pringle maneuver, and histologic changes led to less volume growth. In patients younger than 60 years with CRLM, 90-day mortality was similar to conventional 2-stage hepatectomies for CRLM. Conclusions: This is the first analysis of the ALPPS registry showing that ALPPS has increased perioperative morbidity and mortality in older patients but better outcomes in patients with CRLM.
Palavras-chave
ALPPS, hepatectomy, hypertrophy, liver tumors, portal vein (qualifier surgery)
Referências
  1. Aloia TA, 2012, ANN SURG, V256, pe16
  2. Aloia TA, 2012, ANN SURG, V256, pe9
  3. Alvarez FA, 2013, J GASTROINTEST SURG, V17, P814, DOI 10.1007/s11605-012-2092-2
  4. Balzan S, 2005, ANN SURG, V242, P824, DOI 10.1097/01.sla.0000189131.90876.9e
  5. Balzan S, 2005, ANN SURG, V242, P828, DOI 10.1097/01.SLA.0000189131.90876.9E
  6. Breitenstein S, 2010, ANN SURG, V252, P726, DOI 10.1097/SLA.0b013e3181fb8c1a
  7. Brouquet A, 2011, J CLIN ONCOL, V29, P1083, DOI 10.1200/JCO.2010.32.6132
  8. Clavien PA, 2009, ANN SURG, V250, P187, DOI 10.1097/SLA.0b013e3181b13ca2
  9. Clavien P, 2007, NEW ENGL J MED, V356, P1545, DOI 10.1056/NEJMra065156
  10. de Santibanes E, 2012, ANN SURG, V255, P415, DOI 10.1097/SLA.0b013e318248577d
  11. Dindo D, 2008, WORLD J SURG, V32, P939, DOI 10.1007/s00268-008-9584-y
  12. Dokmak S, 2012, ANN SURG, V256, pe6
  13. Dokmak S, 2012, ANN SURG, V256, pe16
  14. Donati M, 2013, WORLD J GASTROENTERO, V19, P6548, DOI 10.3748/wjg.v19.i39.6548
  15. Jaeck D, 2004, ANN SURG, V240, P1037, DOI 10.1097/01.sla.0000145965.86383.89
  16. Jaeck D, 2004, ANN SURG, V240, P1049
  17. Jarnagin William R, 2002, Ann Surg, V236, P397
  18. Knoefel WT, 2013, BRIT J SURG, V100, P388, DOI 10.1002/bjs.8955
  19. Kokudo Norihiro, 2013, Updates Surg, V65, P175, DOI 10.1007/s13304-013-0215-2
  20. Lameire N, 2008, LANCET, V372, P1863, DOI 10.1016/S0140-6736(08)61794-8
  21. Li J, 2013, J GASTROINTEST SURG, V17, P956, DOI 10.1007/s11605-012-2132-y
  22. Machado MA, 2013, ANN SURG ONCOL, V20, P1491, DOI 10.1245/s10434-013-2920-y
  23. McCulloch Peter, 2009, Lancet, V374, P1105, DOI 10.1016/S0140-6736(09)61116-8
  24. Nadalin S, 2014, Z GASTROENTEROL, V52, P35, DOI 10.1055/s-0033-1356364
  25. Oldhafer KJ, 2014, WORLD J SURG, V38, P1504, DOI 10.1007/s00268-013-2401-2
  26. Schadde E, 2014, WORLD J SURG, V38, P1510, DOI 10.1007/s00268-014-2513-3
  27. Schnitzbauer AA, 2012, ANN SURG, V255, P405, DOI 10.1097/SLA.0b013e31824856f5
  28. Selzner M, 2000, HEPATOLOGY, V31, P35, DOI 10.1002/hep.510310108
  29. Selzner M, 1999, HEPATOLOGY, V30, P469, DOI 10.1002/hep.510300215
  30. Shindoh J, 2013, J AM COLL SURGEONS, V217, P126, DOI 10.1016/j.jamcollsurg.2013.03.004
  31. Torres Orlando Jorge Martins, 2013, ABCD, arq. bras. cir. dig., V26, P40, DOI 10.1590/S0102-67202013000100009
  32. Tsai SS, 2010, HPB, V12, P262, DOI 10.1111/j.1477-2574.2010.00161.x
  33. Vauthey JN, 2002, LIVER TRANSPLANT, V8, P233, DOI 10.1053/jlts.2002.31654